Overview

The resources below provide guidance for the health care sector in managing °ä°¿³Õ±õ¶Ù‑19 in health care organizations and long-term care and retirement homes.

Case definition

The case definition for °ä°¿³Õ±õ¶Ù‑19 has been updated and is current as of September 2023. This information is subject to change. Please check back often for updates.

For clinical testing purposes: health professionals who are involved in the assessment and management of possible °ä°¿³Õ±õ¶Ù‑19 cases are encouraged to consult Tables 1 and 2 in the daily to help inform their decision making.

Travelers from outside of Canada

Requirements for entry into Canada may change over time. For updated information, please visit the 's website for travel advice and the Ministry of Health website dedicated to COVID-19.

Guidance documents

Guidance documents on °ä°¿³Õ±õ¶Ù‑19 have been produced for a number of health and other sectors.

Note: To the extent that any guidance document conflicts with a issued by the Chief Medical Officer of Health under s. 77.7 of the Health Protection and Promotion Act, the Directive prevails.

For controlled drugs and substances (CDS) prescribers

Health Canada is moving forward with regulatory exemptions to improve pharmacological and therapeutic options for allowing patients to access controlled medications during the °ä°¿³Õ±õ¶Ù‑19.

Disclaimer

If you require this information in an alternative format, please contact infoline.moh@ontario.ca. We will:

  • acknowledge your request within three business days
  • provide you with the content within 15 business days